Home
>
National Drug Code (NDC)
>
Pentoxifylline
Pentoxifylline - 76237-225-30 - (Pentoxifylline)
Drug Information of Pentoxifylline
| Product NDC: | 76237-225 |
| Proprietary Name: | Pentoxifylline |
| Non Proprietary Name: | Pentoxifylline |
| Active Ingredient(s): | 400 mg/1 & nbsp; Pentoxifylline |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Pentoxifylline
| Product NDC: | 76237-225 |
| Labeler Name: | McKesson Contract Packaging |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074425 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120130 |
Package Information of Pentoxifylline
| Package NDC: | 76237-225-30 |
| Package Description: | 6 BLISTER PACK in 1 BOX, UNIT-DOSE (76237-225-30) > 5 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK |
NDC Information of Pentoxifylline
| NDC Code | 76237-225-30 |
| Proprietary Name | Pentoxifylline |
| Package Description | 6 BLISTER PACK in 1 BOX, UNIT-DOSE (76237-225-30) > 5 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK |
| Product NDC | 76237-225 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Pentoxifylline |
| Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20120130 |
| Marketing Category Name | ANDA |
| Labeler Name | McKesson Contract Packaging |
| Substance Name | PENTOXIFYLLINE |
| Strength Number | 400 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Blood Viscosity Reducer [EPC],Hematologic Activity Alteration [PE] |
